Product Information

PREGABALIN 150 MG CAPSULE is a generic product labeled by Tris Pharma Inc, priced at $0.0641 per EA under NDC 27808023801. Its NADAC has been published 133 times since Aug 24, 2022.

FDA first approved this application on Jul 15, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PREGABALIN 150 MG CAPSULE

Pregabalin
$0.0641per EA
DEA Schedule CV

Strength

150 mg/1

Manufacturer

Tris Pharma Inc

NDC

27808023801

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

2/19/2025

Active Ingredients

PREGABALIN

Approval Type

Generic (ANDA)

FDA Application

ANDA214322

FDA Approved

7/15/2021

TE Code

AB

On Market Since

7/15/2021

Price Statistics

The NADAC for PREGABALIN 150 MG CAPSULE has been published 133 times since Aug 24, 2022, and over the history we have for it it has declined 21.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0641 per EA
All-time high$0.0905 (Oct 12, 2022)
All-time low$0.0494 (Nov 20, 2024)
Median price$0.0704
Average price$0.0703
Largest weekly change+32.6% (Aug 21, 2024)
Weeks tracked133
Tracking sinceAug 24, 2022

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

-20.0%

5Y

N/A

All

-21.4%

Last surveyed Mar 5, 2025 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 20% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Frequently asked questions

What is the NADAC price of PREGABALIN 150 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for PREGABALIN 150 MG CAPSULE, manufactured by Tris Pharma Inc, is $0.0641 per EA (NDC 27808023801), effective Mar 5, 2025.

How has the price of PREGABALIN 150 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for PREGABALIN 150 MG CAPSULE has declined 21.4%. It has been tracked across 133 weekly CMS publications since Aug 24, 2022.

What are the highest and lowest recorded NADAC prices for PREGABALIN 150 MG CAPSULE?

Since Aug 24, 2022, the NADAC for PREGABALIN 150 MG CAPSULE has ranged from a low of $0.0494 (Nov 20, 2024) to a high of $0.0905 (Oct 12, 2022), with a median of $0.0704 per EA.

Are there cheaper alternatives to PREGABALIN 150 MG CAPSULE?

Yes. 11 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PREGABALIN 150 MG CAPSULE, is $0.0510 per EA — about 20% below PREGABALIN 150 MG CAPSULE.

Who manufactures PREGABALIN 150 MG CAPSULE?

PREGABALIN 150 MG CAPSULE (NDC 27808023801) is labeled by Tris Pharma Inc, and CMS classifies it as a generic product.